Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/1993
10/28/1993WO1993020816A1 Angiotensin ii antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy
10/28/1993WO1993020808A1 Aminoguanidine spray drying process
10/28/1993WO1993020807A1 Amines as inhibitors of squalene synthase
10/28/1993WO1993020696A1 Regulation of the immune system
10/28/1993WO1993009222A3 Transfection of vertebrate cells e.g. by homologous recombination
10/28/1993CA2133090A1 Endothelin antagonists ii
10/28/1993CA2130578A1 Taxol derivatives
10/28/1993CA2130198A1 Method of administering pyruvate and methods of synthesizing pyruvate precursors
10/28/1993CA2130096A1 3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives; process for preparing the same and therapeutic agents containing them
10/27/1993EP0567433A1 Orally-ingestible nutrition compositions having improved palatability
10/27/1993EP0567391A1 A biodegradable tgf-beta delivery system for bone regeneration
10/27/1993EP0567353A1 Use of 1-alpha,25-dihydroxy-22(E)-dehydro-vitamin D3 for the manufacture of a medicament for the treatment of osteoporosis
10/27/1993EP0567352A1 Use of 1-alpha,24(R)-dihydroxy-22(E)-dehydro-vitamin D3 for the manufacture of a medicament for the treatment of osteoporosis
10/27/1993EP0567088A2 Processes for the preparation of amylase inhibitor
10/27/1993EP0566732A1 Adeno-associated virus-2 basal vectors
10/27/1993EP0566698A1 Amino-substituted pyrimidines, derivatives and methods of use therefor
10/27/1993EP0566647A1 Improved humanized immunoglobulins
10/26/1993US5256697 Covalently linked pyruvyl-amino compound
10/26/1993CA1323575C Use of bezafibrate for treating diabetes
10/25/1993CA2093836A1 Biodegradable tgf-.beta. delivery system for bone regeneration
10/20/1993EP0566535A1 Compositions comprising methanediphosphonic acids and ion-exchangers
10/20/1993EP0566405A2 Aqueous gel retinoid dosage form
10/20/1993EP0565683A1 Quinoxaline derivates with affinity for quisqualate-receptors
10/20/1993EP0565634A1 Angiotensin ii receptor blocking compositions
10/19/1993US5254715 Anticholesterol agents
10/19/1993US5254594 Remedies for bone diseases
10/19/1993US5254590 Acylaminophenol compounds
10/19/1993US5254549 New BHT ether compounds and their use as hypolipidemic and antiatherosclerotic drugs
10/19/1993US5254544 Anticholesterol
10/19/1993CA1323367C Phenyl-substituted piperidine compounds and their preparation and use in treating calcium overload in brain cells of mammals
10/14/1993WO1993020439A1 Compositions and methods for regulating cellular signal transducing systems
10/14/1993WO1993020073A1 Indole derivatives as 5-ht1 agonists
10/14/1993WO1993020059A1 Hydrazide derivatives of 3,4-dihydro-2h-1-benzopyrans
10/14/1993WO1993019756A1 The use of quinoline-3-carboxamide compounds for treatment of diabetes
10/14/1993DE4212529A1 Verwendung von µ-Carbolinen als nicht-kompetitive Glutamat-Antagonisten Use of μ-carbolines as a non-competitive glutamate antagonists
10/14/1993CA2132624A1 Compositions and methods for regulating cellular signal transducing systems
10/13/1993EP0565317A1 (2-(2-hydroxy-2 phenylethylamino)ethoxy) phenyl derivatives, processes and intermediates for their preparation, pharmaceutical compositions containing them and their use as Beta-3-adrenoceptor agonists
10/13/1993EP0564804A1 Improved high protein liquid nutrition for patients with elevated wound healing requirements
10/13/1993EP0564592A1 Liver enriched transcription factor
10/12/1993US5252722 5-O-α-D-glucopyranosyl-L-ascorbic acid
10/12/1993US5252707 Inositol derivative and method for preparing same
10/12/1993US5252705 Peptide derivatives
10/12/1993US5252604 Compositions of retinoic acids and tocopherol for prevention of dermatitis
10/12/1993US5252571 Antidiabetic agents
10/12/1993US5252479 Safe vector for gene therapy
10/11/1993WO1993020820A1 USE OF β-CARBOLINES
10/11/1993CA2117755A1 Use of .beta.-carbolines
10/11/1993CA2093604A1 Chemical compounds
10/11/1993CA2093453A1 High protein liquid nutrition for patients with elevated wound healing requirements
10/10/1993CA2093777A1 Therapeutic amines
10/06/1993EP0563731A1 Medicaments containing polyhydroxymethylene-derivatives, process for their manufacture and use thereof
10/06/1993EP0563301A1 Alteration of rate and character of hair growth
10/06/1993EP0563112A1 Enhanced bioavailability pharmaceutical composition containing probucol.
10/06/1993EP0563107A1 Novel methylenebisphosphonic acid derivatives
10/06/1993EP0563096A1 Novel methylenebisphosphonic acid derivatives
10/06/1993CN1022325C Azolidinedione derovatives
10/05/1993US5250524 Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals
10/05/1993CA1322761C Organogermanium compounds and process for producing the same
10/05/1993CA1322719C Activator for osteoblast
09/1993
09/30/1993WO1993019162A1 Fatty acid microspheres containing enterococcus for use to enhance growth and improve carcass quality
09/30/1993WO1993019085A1 Novel antler-derived bone growth factors
09/30/1993WO1993019063A1 Benzodiazepine derivatives, compositions containing them and their use in therapy
09/30/1993WO1993019044A1 Novel vitamin d analogues
09/30/1993WO1993018786A1 Use of a peptide
09/30/1993WO1993018785A1 Novel medicament
09/30/1993WO1993018774A1 Use if estriol for treating climacteric osteoporosis
09/30/1993WO1993018668A1 A salt product and a method for the preparation thereof
09/30/1993CA2132219A1 Novel antler-derived bone growth factors
09/30/1993CA2131790A1 Fatty acid microspheres containing enterococcus for use to enhance growth and improve carcass quality
09/30/1993CA2130195A1 Benzodiazepine derivatives, compositions containing them and their use in therapy
09/30/1993CA2120703A1 Novel vitamin d analogues
09/29/1993EP0563001A1 Imidazole compounds, their preparation and use
09/29/1993EP0562643A2 7-Substituted-hept-6-enoic and -heptanoic acids and derivatives thereof
09/29/1993EP0562512A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines
09/29/1993EP0562508A2 Protein with bone formation ability and process for its production
09/29/1993EP0562083A1 Vanadyl complexes of hydroxamate chelators and pharmaceutical compositions comprising them
09/29/1993EP0561960A1 Leukemia inhibitory factor receptors
09/29/1993EP0561939A1 Use of angiotensin ii receptor antagonists in the treatment of diabetic nephropathy
09/29/1993EP0561901A1 Use of angiotensin ii receptor antagonists in the treatment of diabetic retinopathy
09/29/1993EP0561877A1 Compounds and compositions which inhibit bone resorption
09/29/1993EP0561772A1 A new pharmaceutical use of fusidic acid and derivatives thereof
09/29/1993CN1076696A Pharmaceutical compounds
09/29/1993CN1076691A Sulfonamido-and sulfonamidocarbonyl-pyridin-2-carbonsaureamide as well as pyridin-n-oxide thereof
09/28/1993US5248699 Hydrochloride salt, antidepressant, anorectic
09/28/1993US5248697 For treatment of radiation associated oxidative damage in tissue
09/28/1993US5248695 Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in animal feeds
09/28/1993US5248507 Hypertonic isochloremic formulation for circulatory shock
09/28/1993CA2092768A1 Protein with bone formation ability and process for its production
09/28/1993CA1322529C Dosage form of fenofibrate
09/25/1993CA2092276A1 Sulfonamido- and sulfonamidocarbonylpyridine -2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals
09/22/1993EP0561408A1 Agent for treatment of chronic fatigue syndrome
09/22/1993EP0561195A1 An invigorating herbal gel for supple skin
09/22/1993EP0561175A1 Pyrimidine derivatives and pharmaceutical compostions containing them
09/22/1993EP0561141A1 Highly concentrated amino acid solution
09/22/1993EP0423151B1 Glycosaminoglycan salts, processes for the preparation thereof and pharmaceutical compositions containing them
09/21/1993US5247102 Cyclization of a resorcinol derivative with ethyl orthoformate in the presence of a base
09/21/1993US5247079 Chemical intermediates for tranquilizers
09/21/1993US5246971 Method of inhibiting nitric oxide formation
09/21/1993US5246951 Nonsteroidal antiinflammatory agents
09/21/1993US5246929 Prophylaxis or treatment of ischemic encephalopathia